Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

Objectives To assess the benefits and harms of reboxetine versus placebo or selective serotonin reuptake inhibitors (SSRIs) in the acute treatment of depression, and to measure the impact of potential publication bias in trials of reboxetine. Design Systematic review and meta-analysis including unpu...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyding, Dirk, Lelgemann, Monika, Grouven, Ulrich, Härter, Martin, Kromp, Mandy, Kaiser, Thomas, Kerekes, Michaela F, Gerken, Martin, Wieseler, Beate
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954275/
https://www.ncbi.nlm.nih.gov/pubmed/20940209
http://dx.doi.org/10.1136/bmj.c4737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954275/
https://www.ncbi.nlm.nih.gov/pubmed/20940209
http://dx.doi.org/10.1136/bmj.c4737

Ejemplares similares